TIMP3 effects are exerted through a mechanism independent from glycemic control and may contribute to a significant improvement in the effectiveness of the treatments to prevent and/or reduce the progression of diabetic nephropathy, one of the top three causes of terminal kidney disease in the Western world. Here, TIMP3 is linked to diabetic kidney disease.